Progyny, Inc. EV/EBIT

EV/EBIT of PGNY for past 10 years: annual, quarterly and twelve month trailing (TTM) including EV/EBIT growth rates and interactive chart. EV/EBIT is a ratio that compares a company’s Enterprise Value (EV) to its Earnings Before Interest, Taxes (EBIT), but after Depreciation and Amortization.. The EV/EBIT ratio is a valuation metric used to compare the relative value of different businesses. A low EV/EBIT compared to a stock’s historical average or industry can indicate undervaluation. EV/EBIT takes into account the reinvestment needs of a business (depreciation, amortization).


Highlights and Quick Summary

Current EV/EBIT of Progyny, Inc. is 427.59 (as of December 30, 2020)
  • EV/EBIT for the quarter ending June 29, 2021 was 173.74 (a -23.39% decrease compared to previous quarter)
  • Year-over-year quarterly EV/EBIT decreased by -36.85%
  • Annual EV/EBIT for 2020 was 427.59 (a 738.37% increase from previous year)
  • Annual EV/EBIT for 2019 was 51.0 (a 248.78% increase from previous year)
  • Annual EV/EBIT for 2018 was 14.62 (a 0.0% decrease from previous year)
Visit stockrow.com/PGNY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EV/EBIT of Progyny, Inc.

Most recent EV/EBITof PGNY including historical data for past 10 years.

Interactive Chart of EV/EBIT of Progyny, Inc.

Progyny, Inc. EV/EBIT for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 173.74 226.79
2020 427.59 275.11 321.74 170.48 427.59
2019 51.0 14.62 14.62 14.62 51.0
2018 14.62 14.62
2017 14.62

Business Profile of Progyny, Inc.

Sector: Healthcare
Industry: Health Information Services
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.